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ORIGINAL ARTICLE
Women’s Limited Choice and Availability of Modern
Contraception at Retail Outlets and Public-Sector Facilities in
Luanda, Angola, 2012–2015
Benjamin Nieto-Andrade,a Eva Fidel,a Rebecca Simmons,b Dana Sievers,c Anya Fedorova,a Suzanne Bell,d
KarenWeidert,e Ndola Pratae
Despite high rates of unintended pregnancy, access to a wide range of contraceptive methods, especially
injectables and long-acting reversible contraceptives (LARCs), is severely limited in both public and private
facilities. Knowledge of contraceptive choices is likewise limited, yet a substantial proportion of women are
not using their preferred method among the methods they know of.
ABSTRACT
In Angola, many women want to use family planning but lack access to affordable and preferred methods. This article
assesses the link between women’s choice and availability of contraceptive methods in Luanda, Angola, drawing on
data from 3 surveys: a 2012 survey among women ages 15–49 and 2 retail surveys conducted in 2014 and
2015 among outlets and facilities offering contraceptive methods. Descriptive statistics for women’s contraceptive knowl-
edge, use, and preferred methods were stratified by age group. We report the percentage of establishments offering dif-
ferent methods and brands of modern contraception, and the mean price, volume of units sold, and value (Angolan
Kwanzas) for each brand. Data from the 2 retail surveys are compared to measure changes in availability over time.
Results show that 51% of women reported having an unwanted pregnancy. Less than 40% of women knew about long-
acting reversible contraceptives (LARCs). Overall, the method most commonly used was male condoms (32.1%), with a
substantial proportion (17.3%) of women not using their preferred contraceptive. Trends in contraceptive use mirror avail-
ability: in 2015, condoms were available in 73.6% of outlets/facilities, while LARC methods were available in less than
10%. The availability of different methods also dropped significantly between 2014 and 2015—by up to 15 percentage
points—with a subsequent price increase in many brands. To meet women’s needs for contraception and make informed
choice possible, Angola should reinforce demand creation and contraceptive supply in both the public and private sectors
through behavior change programs aimed at both women and providers, improved quality of services, training of health
personnel on method options and delivery, and improved supply chain distribution of contraceptives. This will allow
women to find the methods and brands that best suit their needs, preferences, and ability to pay.
INTRODUCTION
Angola’s slow recovery after almost 30 years of civilwar has led to the country’s unique demographic
situation compared with other similarly developed
sub-Saharan African nations.1,2 Specifically, women in
Angola were less likely to have children during wartime,
particularly in areas where the impact was the most
intense; the probability of having a child was only
39% in 1994 during the intense war period, compared
with 52% in 1996 when fighting was at a stalemate.3
The temporary decline in childbearing during the
war did not result, however, in a long-term reduction in
fertility: in 2014, the total fertility rate was 5.7 births
per woman, one of the highest rates in the world.4
Geographic differences in fertility are stark, with women
in rural areas having an average of 3 more children than
women in urban areas.5 Over time, the age-specific fer-
tility rate among adolescents increased faster than that
of olderwomen.For example, from2006 to2011 theage-
specific fertility rate among 15–19-year-olds increased
from 151 to 188 births per 1,000 women, compared
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with an increase from 242 to 244 births per
1,000 women among 30–34-year-olds.6 High
fertility rates are often associated with high
maternal and child mortality. In Angola, the
infant mortality rate is 96 per 1,000 live births
and the maternal mortality ratio is 460 per
100,000 live births.7,8
Not surprisingly, the contraceptive prevalence
rate (CPR) is low (17.7% for modern and tradi-
tional methods; 12.8% for modern methods
only), with significant differences by geography
(27% of urban women use contraception vs.
7% of rural women) and income level (28.1% of
women in the wealthiest quintile vs. 1.4% of
women in the poorest).5,8,9 Contraceptive use is
also associated with education, marital status, and
previous childbearing experience. A study in
Luanda, the capital of Angola, found that sexually
active women who are unmarried, less educated,
and have never given birth are less likely to be
users of any method of contraception.10 More
than half of women who were not using contra-
ception at the time of the study reported feeling
that contraception was inaccessible, underlying
the importance of improving method availability
and choice.10
Women’s preferences for particular methods
are based on a multitude of factors, including
cost, ease of use, efficacy, side effects (both real
and perceived), and partner relationships, among
many others factors. Having a full range of family
planning options is considered an important com-
ponent of quality of care and informed choice,
resulting in improved uptake of family planning.11
Access to more methods increases the odds that a
woman will use and continue to use contracep-
tion: for each additional method widely available
in a country, the percentage of married women
using contraception increases by an average of
3.3 percentage points.12 At the same time, greater
availability of contraceptive brands generates
competition in the market, increasing chances of
price reduction and improving women’s access to
contraceptives within the private sector.13
Angola’s national family planning program
began in themid-1980swith the goal of improving
maternal health by spacing pregnancies.15 The
program promised to offer free family planning
services through state-run public clinics (mater-
nity hospitals, health centers, and health posts),
but implementation has been difficult due to the
limited number of trained providers and inconsis-
tent supply of contraceptive commodities.2,15–17
When the public sector experiences stock-outs of
short-acting methods, women might be directed
to get contraceptives from the private sector,
which is comprised of small local pharmacies
(boteco), modern pharmacies (e.g., Mecofarma),
and private clinics.18,19 In the case of condoms,
the private sector also includes non-traditional
establishments such as local stores, markets, gas
stations, and hotels.
The public sector obtains contraceptives
through donations from the United States Agency
for International Development (USAID) or the
UnitedNationsPopulationFund(UNFPA).Specific
brands of oral contraceptive pills (Microgynon,
Microlut), injectables (Depo-provera), and
implants (Jadelle) are donated exclusively for
the public sector for free. In 2015, the private
sector generally obtained contraceptives from
wholesalers (including Princefarma, Shalina,
Farwell, and Ecofarma, among others) who
import products mostly from Europe and Asia
and, in some cases, from Angolan border coun-
tries.20,21 The products in the private sector
include a wide range of brands for condoms
(Davigra, Kamasutra, Durex, among others),
oral contraceptive pills (e.g., Yasmin, Diane35),
and oral emergency contraceptives (Pilula S
and Norlevo).20,21
Angola’s family planning strategy currently
centers on strengthening supply so that women
can choose from a range of affordable products
and services needed to space or limit pregnancies.
Angola’s National Health Development Plan is
bolstering health systems to increase the propor-
tion of facilities offering family planning and
better distribute qualified providers.22 UNFPA
helped obtain more than 60% of the country’s
family planning commodities, and its program for
2015–2019 allocates US$12 million to strengthen
the supply chain and integrate activities for family
planning, maternal health, and prevention of
sexually transmitted infections (STIs) including
HIV.9 In its 2014–2017 Country Development
Cooperation Strategy, USAID will use a market-
based approach to support the local commercial
sector to supply a suite of contraceptive products
to women at different income levels.22
Based on the existing literature, little is
known about the availability of different con-
traceptive methods in Angola or the choices
women make. This article helps to contribute
to the discussion by presenting results from a
population-based survey (2012) and two retail
studies (2014 and 2015), all conducted in
Luanda, Angola, to understand women’s con-
traceptive choices and their link with contra-
ceptive availability in the market.
Little is known
about the
availability of a
range of
contraceptive
methods in
Angola or the
choices women
make.
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MATERIALS AND METHODS
Data Sources
This analysis draws on data from 3 surveys con-
ducted by Population Services International (PSI)
to understand women’s choices and availability of
contraception.
Family Planning Survey 2012. The
2012 study, conducted in collaboration with
the Bixby Center at the University of California
Berkeley, surveyed women ages 15–49 in Luanda
province between October and November 2012.
The purpose of the surveywas to assess contracep-
tive use and fertility preferences, as well as barriers
to and drivers of contraceptive use. The question-
naire was based on a standard PSI questionnaire
that explores the opportunity, ability, andmotiva-
tional variables to use contraception, and it bor-
rowed elements of the family planning section
of the Angola Malaria Indicator Survey 2011 and
of the Women’s Questionnaire supplement to
the Demographic and Health Surveys (DHS)
2008–2013.6,23 A total sample of 1,545 women
completed the survey through multistage random
sampling. First, the sample size was distributed
proportionally to the size of each municipality.
Then a number of sampling points (churches, hos-
pitals, gas stations, etc.) were randomly selected in
each municipality from a list created for that pur-
pose. The number of sampling points chosen per
municipality varied according to its population
size. Within each of these sampling points, a fixed
number of households was selected. One woman
within the age criteria was then randomly chosen
and invited to participate. PSI hired a research
marketing agency, SINFIC (Sistemas de Informação
Industriais e Consultoria), to conduct the fieldwork.
Retail Survey 2014. PSI conducted an audit
survey among retail stores and health facilities in
Luanda province from June to September 2014 to
learn about the availability of different contracep-
tive methods, the brands available for each
method, the units sold, the price, and stock-out
problems. SINFIC was also hired to conduct the
fieldwork for this study. The survey included a
census of all establishments selling or distributing
at least 1 type of contraceptive in the entire prov-
ince of Luanda (301 bairros), including pharma-
cies, drug dispensing units in public hospitals,
supermarkets, grocery stores, kiosks, gas stations,
bars/discos, and hotels. Of the 2,173 establish-
ments identified, 1,833 completed the interview
(84.3% response rate). Reasons for not partici-
pating were (1) establishment was closed dur-
ing fieldwork, or (2) absence of manager or
owner who could provide permission. Three
visits were made to the establishment before
desisting from the interview. Establishments
participating in the study were similar to those
not participating in terms of establishment type.
Of the final sample, 2.8% of the establishments
were from the public sector (96.1% drug dis-
pensing units at public health centers and
3.9% NGOs), while 97.2% were private-sector
outlets (76.6% boteco, 10.0%modern pharmacies,
6.7%pharmacies of private clinics, and6.0%other
type of outlet such as kiosks, local stores, street
vendors, hotels, and gas stations).
Retail Survey 2015. This second round of the
retail study also measured contraceptive availabil-
ity, brand market share, and price. It used the
same data collection instrument as in 2014, but
unlike the first round, it selected only 50 neigh-
borhoods (bairros) at random out of a total of
301 in the entire province. Within those selected
neighborhoods, a census of all establishments was
conducted. Based on the levels of contraceptive
availability detected in 2014, sample sizes for
outlets were calculated for each method pro-
vided, assuming a 95% confidence interval,
84.0% response rate, 80% power, 2-sided signifi-
cance tests, and a design effect of 2. The number
of completed interviews needed for each method
(after discounting the 16.0% non-response
rate), was (1) 344 establishments for condoms,
(2) 501 establishments for injectable methods,
(3) 769 establishments for oral contraceptive pills,
and (4) 820 for emergency oral contraceptive pills.
Details of the sampling formula can be found else-
where.24,25 Fieldwork was conducted by PSI/
Angola. A total of 957 establishments were identi-
fied and invited to participate; 766 completed the
interview (80.0% response rate). No notable dif-
ferences were found in the type of establishments
that participated in the study comparedwith those
that did not. Of the 766 establishments included
in this analysis, 3.5% were public-sector outlets
(85.2%drug dispensing units at public health cen-
ters, 7.4% public maternities, and 7.4% NGOs),
while 96.5% were private-sector outlets (62.0%
boteco, 19.5% modern pharmacies, 3.5% pharma-
cies of private clinics, and 15.0% other type of
outlet).
Data Analysis
Family Planning Survey 2012. Descriptive sta-
tistics are presented in this article, including: socio-
demographics of the sample, pregnancy intention
(measured by whether women wanted their last
pregnancy at the time it happened, wanted it later,
A 2012
population-based
study in Luanda
province assessed
contraceptive use
and fertility
preferences as
well as barriers to
and drivers of
contraceptive use.
Two audit surveys
among retail
stores and health
facilities
conducted in 2014
and 2015
measured
contraceptive
availability, brand
market share, and
price.
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or did not want more children at all), contraceptive
knowledge (prompted), contraceptive use (the per-
centage of sexually active women using modern
methods), as well as the unmet need for preferred
contraception (defined as the percentage of sexually
active, fecund women who are currently using
contraception but report that their current
method is not their preferred method). Main
results are presented for the overall sample and
by age group. Given that adolescent women
generally face greater barriers in accessing
reproductive health services, 2 age groups were
created from the sample of young women: ages
15–19 and ages 20–24. Women aged 25 and
older comprised the final age group.
Retail Surveys 2014 and 2015. Availability
of contraceptive methods on the market was cal-
culated for each year, defined as the percentage
of establishments that reported selling or distribut-
ing different types of modern contraceptive meth-
ods. Independent sample t tests were produced to
measure changes over time for the overall samples
and for the private and public sector, separately.
For 2015, market share indicators were pro-
duced, defined as the proportion that each
brand represents within its respective contra-
ceptive category in terms of volume (number
of units sold) and value (Angolan Kwanzas: AKZ),
measured during the 30 days prior to the survey.
No data were presented for 2014 given that the
dominant contraceptive brands remained so in
2015. Availability of brands was also calculated
based on proportion of outlets having specific
brands within the outlets selling or distributing
the corresponding contraceptive category.
Finally, mean price per brand was reported for
each year with its 95% confidence intervals, in
order to measure significant changes over time.
This was calculated as the arithmetic average of
price provided by establishments. This indicator is
presented in local currency, rather than US dol-
lars, to better reflect changes in prices and its
impact on Angolan women: recent depreciation
of AKZ with respect to US dollars could hide the
real cost of contraceptives to consumers if US cur-
rency is used. The exchange rate as of October 30,
2014, was US$1 for 99AKZ.26
Ethical Considerations
The family planning study conducted in
2012 received ethical approval from the Berkeley
Center for Protection of Human Subjects (CPHS #
2011-08-3521) at the University of California
Berkeley, and from the Ethical Committee at the
Public Health Institute in Luanda, Angola. The
retail study in 2014 was commissioned to an
external agency (SINFIC) and followed its internal
ethics processes, which consisted of providing
ethics training to its interviewers to minimize any
potential risk in breach of confidentiality and to
assure justice, beneficence, and respect during
the data collection process; interviewers also
signed a pledge of confidentiality. The retail study
in 2015, conducted by PSI/Angola, went through
PSI’s ethics committee, which deemed the study
to be not human subjects’ research as it was a sur-
vey about product availability. Interviewers still
received training in human subjects to ensure
compliance with ethics principles.
RESULTS
Women’s Fertility Preferences and
Contraceptive Use
Results from the 2012 Family Planning Survey
show a relatively young female population (me-
dian age of 24 years), with more than half hav-
ing completed high school (Table 1). Most of
the women aged 20–24 reported being single
(81.7%) and were sexually active (90.9%).
Although half of them had already been preg-
nant, the majority (72.2%) either did not plan
or did not want their last pregnancy. Younger
women wanted fewer children: women aged
20–24 wanted an average of 3.7 children, while
women 25 years and older desired 4.3 children.
Nearly all women knew about condoms
(95.0%) and, to a lesser extent, oral contraceptive
pills (79.7%) and injectable contraceptives
(68.9%). In contrast, less than half of the respond-
ents knew about long-acting reversible contracep-
tives (LARCs), which consist of intrauterine
devices (IUDs) (39.6%) and implants (38.6%).
Knowledge of LARCs was extremely low in the
youngest age group (15–19): only 19.1% knew
about IUDs and 18.2% knew about implants.
While the overall contraceptive prevalence
rate was relatively high among the study partici-
pants (58.7%), most of it was due to the reported
reliance on condoms, with little to no use of other
methods, especially among the younger age
groups. For example, 52.0% of women 15–19
years old reported using condoms as a family plan-
ningmethod, while only 3.2% reported using oral
contraceptive pills and 2.0% injectable contracep-
tives. Almost no young respondents used implants
(0.4%) or IUDs (0.0%). A similar pattern was
observed in the 20–24 year age group.
Themajority of
women knew
about condoms,
pills, and
injectables, but
less than half
knew about IUDs
or implants.
Although
contraceptive
prevalence was
relatively high
(59%) among
survey
respondents, most
of it was due to the
reported reliance
on condoms.
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TABLE 1. Demographic and Behavioral Characteristics of Women of Reproductive Age in Luanda, Angola, 2012
Variables
Age Groups
15–19
(N=451)
20–24
(N=361)
≥25
(N=729)
All
(N=1545)
Sociodemographics
Age, median NA NA NA 24.0
Marital status
Single 98.2 81.7 39.4 66.5
Married/cohabiting 1.8 18.3 56.0 31.3
Divorced/widowed 0.0 0.0 4.1 2.2
Education
High school or less 55.3 28.8 45.3 44.4
More than high school 44.7 71.2 54.7 55.6
Sexual Behavior and Fertility Preferences
Ever had sex 55.0 90.9 91.4 80.6
Ever been pregnant 11.5 49.9 90.4 57.9
Intention to get pregnant at last pregnancya
Wanted it at that moment 17.3 27.8 57.7 49.3
Wanted it later 53.8 56.1 28.1 35.2
Did not want more children 28.8 16.1 14.3 15.5
Ideal number of children, meanb 3.8 3.7 4.3 4.2
Knowledge of modern contraceptives
Condoms 96.7 95.6 93.7 95.0
Oral contraceptive pills 68.9 84.2 87.4 79.7
Injectable 47.2 65.7 84.1 68.9
Female condoms 34.2 42.1 54.7 45.6
IUD 19.1 36.3 54.2 39.6
Implants 18.2 35.7 52.7 38.6
Female sterilization 14.6 26.6 39.4 29.1
Emergency oral contraceptive pills 10.3 21.6 32.8 23.5
Male sterilization 5.3 12.5 22.2 15.0
Contraceptive Usec
Current prevalence of any modern contraception 58.5 64.9 55.9 58.7
Continued
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TABLE 1. Continued
Variables
Age Groups
15–19
(N=451)
20–24
(N=361)
≥25
(N=729)
All
(N=1545)
Current prevalence of:
Condoms 52.0 46.0 17.7 32.1
Injectables 2.0 6.1 18.8 12.1
Oral contraceptive pills 3.2 11.0 14.1 11.1
Implants 0.4 1.5 2.6 1.9
IUD 0.0 0.0 1.4 0.7
Female sterilization 0.8 0.0 0.8 0.6
Female condoms 0.0 0.3 0.6 0.4
Male sterilization 0.0 0.0 0.0 0.0
Ever used emergency contraceptive pillsd 1.1 6.4 5.8 4.5
Current contraceptive users not using their preferred methode 15.1 20.7 16.0 17.3
Preferred contraceptive method among women not using their preferred methodf
Injectables 13.6 25.0 31.0 25.6
Condom 31.8 22.7 8.6 17.6
Implants 13.6 4.6 27.6 16.8
Oral contraceptive pills 4.6 13.6 12.1 12.0
Rhythm method 4.6 0.0 1.7 1.6
Female condom 4.6 0.0 0.0 0.8
Female sterilization 0.0 0.0 1.7 0.8
None 13.6 20.5 0.0 9.6
Other 13.6 13.6 17.2 15.2
Abbreviation: IUD, intrauterine device.
All data are reported as percentages unless otherwise noted.
a Among women ever pregnant (N=52 among 15–19-year-olds; N=180 among 20–24-year-olds; N=659 among ≥25-year-olds; and N=891 among
the entire sample of women).
b Among women who have given birth (N=25 among 15–19-year-olds; N=128 among 20–24-year-olds; N=608 among ≥25-year-olds; and N=764
among the entire sample of women).
c Among women who have had sex (N=248 among 15–19-year-olds; N=328 among 20–24-year-olds; N=666 among ≥25-year-olds; and N=1245
among the entire sample of women).
d The survey did not explicitly include emergency contraceptive pills as an option for current method but included a question on ever use of emergency con-
traceptive pills.
e Among fecund women who have had sex and who are currently using contraception (N=146 among 15–19-year-olds; N=213 among 20–24-year-olds;
N=363 among ≥25-year-olds; and N=722 among the entire sample of women).
f N=22 among 15–19-year-olds; N=44 among 20–24-year-olds; N=58 among ≥25-year-olds; and N=125 among the entire sample of women.
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There was some discrepancy between actual
and preferred contraceptive method use: women
were looking for a wider range of alternatives
than what they actually had. Overall, 17.3% of
women currently using contraception reported
notusing their preferredmethod.Of thesewomen,
the most commonly reported preferred method
was injectable contraceptives (25.6%), followed
by condoms (17.6%) and implants (16.8%).
In summary, results from the 2012 Family
Planning Survey among women in Luanda illus-
trate a high percentage of unwanted pregnancy
and a lack of knowledge about the full array
of contraceptive methods, particularly LARCs,
which is especially true among younger cohorts.
There is a heavy reliance on condoms as a family
planning method, and there is a substantial per-
centage of women who are not currently using
their preferred contraceptive method.
Contraceptive Availability in Luanda
Data from the 2014 and 2015 Retail Surveys
showed limited choice for contraceptive methods
in Luanda, with a decline in availability over that
period of time (Table 2). Although 85.9% of all
outlets reported having at least 1 method of
contraception in 2015, when the information
was analyzed by method type, it was clear that
women did not have many contraceptive op-
tions. In both years, the most widely available
contraceptivemethod on themarket was themale
condom, present in 81.4% of the outlets visited
in 2014 and in 73.6% of outlets visited in
2015 (P<.001). Following condoms, oral contra-
ceptive pills and emergency contraceptives were
the nextmost availablemethods; however, during
the same period, their availability declined from
58.6% to 43.3% (P<.001) and from 42.4% to
34.4%(P<.01)of outlets, respectively.Availability
of injectable contraceptives declined significantly
by 6.0 percentage points to reach a level of
7.3% in 2015 (P<.001).
When comparing the public and the private
sectors, we observed a larger decrease in the avail-
ability of oral contraceptive pills in the public sec-
tor: while it declined 14.9 percentage points in the
private sector (from 58.7% in 2014 to 43.8% in
2015; P<.001), it dropped 24.5 percentage points
in the public sector (from 54.1% to 29.6%;
P<.05). We did not observe a significant change
in the availability of male condoms in the public
sector, most likely due to the small number of
public-sector facilities. Availability of the male
condom in the private sector, however, dropped
significantly by 7.3 percentage points. Overall,
the male condom was more available in the pri-
vate sector than in the public sector in both
2014 and 2015 (for example, 75.1% in the
private sector versus 33.3% in the public sector
in 2015).
TABLE 2. Availability of Contraceptive Methods by Sector, Luanda, Angola, 2014–2015
Private Sector Public Sector Total
2014 2015 2014 2015 2014 2015
Method (N=1782) (N=739) Difference (N=51) (N=27) Difference (N=1833) (N=766) Difference
Any methoda 97.6 86.9 10.7*** 84.3 59.3 25.0* 97.2 85.9 11.3***
Male condom 82.3 75.1 7.3*** 49.0 33.3 15.7 81.4 73.6 7.8***
Oral contraceptive pillsb 58.7 43.8 14.9*** 54.1 29.6 24.5* 58.6 43.3 15.3***
Emergency contraceptive pillsb 43.3 35.8 7.5** 11.8 11.1 0.7 42.4 34.4 7.5**
Injectablesb 13.1 6.6 7.56.5*** 19.6 18.5 1.1 13.3 7.3 6.0***
All data for 2014 and 2015 reported as percentages; the differences between 2014 and 2015 are percentage points.
*P<.05; ** P<.01; *** P<.001.
a Any method includes at least one of the following: condoms, oral contraceptive pills, emergency contraceptive pills, injectable methods, hormonal patches,
spermicides, intrauterine devices (IUDs), mini-mola or Essure (a non-surgical permanent method for women), and Vasalgel (a long-acting gel similar to no-
scalpel vasectomy but likely more reversible). Less than 5% of the outlets overall reported having hormonal patches, female condoms, spermicides, IUDs,
vaginal rings, or implants. Only 0.1% reported providing mini-mola or Essure or Vasalgel.
b Gas stations, hotels, and bars were not included in the calculation of oral contraceptive pills, emergency contraceptive pills, or injectable availability, since
those outlets mainly distribute or sell condoms.
17% of women
currently using
contraceptive
reported not using
their preferred
women.
Although 86% of
all outlets
reported having
at least 1
contraceptive
method in 2015,
themost widely
availablemethod
on themarket was
the condom.
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TABLE 3. Brand Market Share by Type of Contraceptive Among Outlets Selling the Respective Contraceptive Method,
Luanda, Angola, 2015
Contraceptive Method and Brand
% Outlets Offering
the Brand
Units Sold
Last Montha % Units
Value (AKZ)
Sold
Last Month % Value
Condoms (N=635 outlets)
Sensual 51.8 17,716 22.8 1,295,650 25.6
Legal 37.3 17,092 22.0 845,000 16.7
Davigra 15.6 12,103 15.6 535,530 10.6
Boss Man 11.8 3,153 4.1 176,240 3.5
Kamasutra 9.6 2,193 2.8 6,300 0.1
Control 6.0 4,711 6.1 611,994 12.1
Durex 3.3 8,576 11.0 948,365 18.7
Generic 1.3 7,527 9.7 293,150 5.8
Other brands (þ40) <5.0 each 4,557 5.9 358,795 7.1
Total for condoms NA 77,628 100.0 5,071,024 100.0
Oral contraceptive pills (N=357 outlets)
Microgynon 76.6 2,885 66.0 1,058,303 40.6
Microlut 27.7 457 10.4 141,394 5.4
Yasmin 8.6 234 5.3 434,366 16.4
Diane 35 7.8 108 2.5 167,442 6.4
Other brands (þ10)b <5.0 each 690 15.8 802,642 31.2
Total for oral contraceptive pills NA 4,374 100.0 2,604,147 100.0
Emergency contraceptive pills (N=255 outlets)
Pilula S 45.4 1,064 38.4 656,100 22.7
Ella 24.3 595 21.5 554,200 19.1
IPL72 20.4 463 16.7 330,700 11.4
Norlevo 14.1 6 0.2 1,086,707 37.5
Other brands (7)c <5.0 each 643 23.2 266,518 9.3
Total for emergency contraceptive pills NA 2,771 100.0 2,894,225 100.0
Injectables (N=54 outlets)
Depo-provera 83.3 260 97.7 21,700 94.1
Mesignya 1.9 n/a n/a n/a n/a
Other brands <1.0 each 6 2.3 1,360 5.9
Total for injectables NA 266 100.0 23,060 100.0
Abbreviation: AKZ, Angolan Kwanzas.
a Units are individual condoms for condoms; cycles for oral contraceptive pills; packs for emergency contraceptive pills; and individual units for injectables.
b Other brands of oral contraceptive pills included Cezarette, Climen, Ella, Gynera, Marvelon, Minygesty, etc.
c Other brands of emergency contraceptive pills included CO-Pill, Plan Fam, Levo 72, etc.
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A higher percentage of public-sector establish-
ments distributed injectable contraceptives in
both years (over 18.0%) compared with the pri-
vate sector, which dropped from 13.1% in
2014 to 6.6% in 2015 (P<.001). All othermethods
(hormonal patch, female condoms, spermicides,
IUDs, vaginal rings, and implants), which are
mostly distributed in the public sector, were pres-
ent in less than 5.0% of all establishments in both
years.
Brand Market Share and Price
The number of brands on the market is also an in-
dicator of the number of choices available to
women in terms of quality and price. This section
presents a landscape of the market share (volume
and value) and price for themost available contra-
ceptive methods in 2015. While condoms, oral
contraceptives, and emergency contraceptive pills
have multiple brands in the market, each brand
individually only represents a small proportion of
market. For example, Table 3 shows that only
4 condom brands have a strong individual pres-
ence in terms of sales: Sensual, with 22.8%of total
volume of the market and 25.6% of the total
value (AKZ), followed by Legal (22.0% volume
and 16.7% value), Davigra (15.6% volume and
10.6% value), and Durex (11.0% volume and
18.7% value). Together these 4 brands represent
TABLE 4. Mean Price (Angolan Kwanzas)a for Main Brands of Contraceptives, Luanda, Angola, 2014–2015
Method and Brand [No. of
outlets selling the method
in 2014, 2015]
Mean Price per Unitb (95% CI)
% Change2014 2015
Condoms
Sensual [N=697; N=359] 69.5 (44.3, 72.7) 73.4 (71.2, 75.6) þ5.6%
Legal [N=529; N=237] 36.1 (33.2, 39.0) 46.8 (42.8, 50.8) þ29.8%^
Davigra [N=267; N=99] 59.5 (55.5, 63.5) 58.9 (45.0, 72.7) 1.0%
Durex [N=57; N=21] 119.3 (90.8, 147.8) 200.9 (145.1, 256.8) þ68.4%
Boss Man [N=264; N=71] 54.1 (51.2, 57.0) 60.4 (55.7, 65.2) þ11.7%
Oral contraceptive pills
Microgynon [N=840; N=261] 238.8 (231.7, 245.9) 498.5 (448.3, 548.8) þ108.8%^
Microlut [N=365; N=82] 278.8 (264.5, 293.2) 394.8 (346.0, 443.6) þ41.6%^
Yasmin [N=51; N=43] 705.5 (651.8, 759.3) 2300.2 (2017.5, 2583.0) þ226.0%^
Diane 35 [N=69; N=22] 1068.5 (952.9, 1184.0) 1830.7 (1200.3, 2461.1) þ71.3%^
Emergency contraceptive pills
Pilula S [N=325; N=108] 453.4 (427.3, 479.5) 579.2 (536.0, 622.4) þ27.7%^
Ella [N=225; N=63] 699.3 (657.5, 741.1) 959.0 (659.5, 1258.6) þ37.1%^
IPL72 [N=113; N=46] 509.6 (456.0, 563.3) 700.5 (602.8, 798.2) þ37.5%^
Norlevo [N=109; N=30] 2026.9 (1814.3, 2239.4) 2950.9 (2502.3, 3399.6) þ45.6%ª
Injectables
Depo-provera [N=213; N=45] 351.0 (321.0, 281.1) 482.2 (323.0, 641.5) þ37.4%ª
^ Indicates significant changes based on 95% confidence intervals not overlapping between 2014 and 2015.
a Prices reflect mostly the private sector. According to the National Health Care System, the public sector must offer health services and medicines for free.
The exchange rate as of October 30, 2014, was 99 Angolan Kwanzas for US$1.26
b Units are individual condoms for condoms; cycles for oral contraceptive pills; packs for emergency contraceptive pills; and individual units for injectables.
Of themore than
40 condombrands
on themarket in
Luanda, only 4 of
the brands have
strong presence in
terms of sales.
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over 70.0% of both measures of market share.
Each of the more than 40 other condom brands
available in the market is present in less than
5% of the outlets.
As seen in Table 4, the prices of Sensual and
Legal condoms are among the lowest in the
market: 73 and 46 AKZ per individual condom
in 2015, respectively (about US$0.74 and
$0.47, respectively, given an exchange rate of
99 AKZ for US$1).26 Between 2014 and 2015,
most of these major brands raised their product
price to the final consumer, althoughbycomparing
the95%confidence intervalsaroundthemeanval-
ues in both years,we observed that only in the case
of Legal was the difference statistically significant:
the confidence intervals eachyear donot overlap.
Only 2 oral contraceptive pill brands dominate
the market: Microgynon was present in 76.6% of
establishments selling or distributing oral contra-
ceptive pills, followed by Microlut, which was
present in 27.7% of establishments (Table 3).
These 2 brands are both government/donor-
procured and together represent 76.4% of units
(monthly cycles) sold or distributed and 46.0% of
the value sold in the market. On average, these
2 brands are the most accessible to the final con-
sumer in terms of price: 499 AKZ and 395 AKZ,
respectively, compared with other brands that
ranged in price between 1831 AKZ and 2300 AKZ
per cycle in 2015 (Table 4). All brands of oral
contraceptive pills significantly increased their
price to the consumer bymore than 30% between
2014 and 2015, as judged by comparing the
95% confidence intervals around the mean value
each year.
Similarly, out of 11 brands of emergency
contraceptive pills, 3 non-government-procured
brands dominate the market: Pilula S, Ella, and
IPL72. These brands together represent 76.6% of
units sold and 53.2% of the market value
(Table 3). Like oral contraceptive pills, brands
of emergency contraceptive pills significantly
increased their price from 2014 to 2015 by at least
27% (Table 4).
In summary, data from the 2014 and
2015 Retail Surveys on contraceptives in Luanda
show limited availability of contraceptives. With
the exception of condoms and oral contraceptive
pills, most other types of contraceptive methods
are difficult to find. Even oral contraceptive pills
and condoms are not found in all establishments,
and their overall availability dropped significantly
from 2014 to 2015, while significant increases in
price to final consumer were observed in many
brands. The private sector reported greater
availability of condoms, oral contraceptive pills,
and emergency contraceptives compared with the
public sector, including brands of oral contracep-
tive pills that are government/donor-procured for
the public sector. These brands should only be
available in the public sector for free, yet they are
present in the private sector offering the lowest
prices.
DISCUSSION
The analysis of the Family Planning Survey
2012 and the Retail Surveys 2014/2015 suggests
that limited knowledge and use of a range of con-
traceptive methods, and the limited availability of
LARCs in particular, are interplaying factors shap-
ing the contraceptive market landscape and wom-
en’s choices in Luanda, Angola. Recognizing that
there are other multiple factors affecting the
contraceptive landscape in a country, this article
focuses only on demand and supply. Our findings
suggest that women’s lower knowledge of
LARCmethods (including misconceptions around
them) may explain their lower demand, while the
limited presence of those methods in the market
can also reinforce women’s lower knowledge
and use.
Limited Knowledge and Use of LARCs
The present analysis shows that there were impor-
tant differences in knowledge of contraceptive
methods among women of reproductive age.
Specifically, more women knew about short-
acting methods (such as condoms and oral contra-
ceptive pills) than long-acting methods (IUDs and
implants). Furthermore, knowledge of LARCswas
lower among adolescents than older women, a
result corroborated by other studies that have
found that awareness of different contraceptive
methods varies by age group.27,28 Because limited
knowledge of contraceptive methods can be a bar-
rier to contraceptive use, women of reproductive
age should havemore scientific information about
the different contraceptive methods available to
them.28
Patterns of contraceptive use mirror the levels
of knowledge of each method: male condoms was
the most used contraceptive method across all age
groups, followed at a distance by oral contracep-
tive pills and injectable contraceptives. Although
the use of LARCmethods was generally low across
all age groups, an even smaller percentage of
adolescents used LARCs compared with older
women, a pattern found in other studies.27,29 In
2015, a study conducted by Key Research in
Aswith condoms,
only 2 ofmore
than 10 brands of
oral contraceptive
pills dominate the
market in Luanda.
Most types of
contraceptive
methods are
difficult to find in
Luanda, with the
exception of
condomsandpills.
Limited
knowledge and
use of a range of
methods, along
with limited
availability of
LARCs in
particular, are
interplaying
factors shaping
the contraceptive
market landscape
in Luanda,
Angola.
Patterns of
contraceptive use
in Luandamirror
the levels of
knowledge of
eachmethod.
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Luanda showed that short-acting methods were
the most widely used methods by women, with
condoms as the most-used method (19.1%), fol-
lowed by injectable methods (12.0%) and oral
contraceptives (9.2%). LARC methods were
barely used, particularly among young women.29
This confirms qualitative findings where young
women reported fears of becoming infertile if
they used contraceptive methods other than con-
doms; they all considered that oral contraceptive
pills, injections, and especially LARCs were only
for women who already had children.18 Given
the high fertility rate in Angola, the use of LARCs
by young women could make a positive impact in
reducing not only the fertility rate but also the
rates of unintended pregnancy, unsafe abortion,
and maternal mortality.
Impact of Limited Availability of
Contraceptives onWomen’s Choices
The present analysis also shows limited availabil-
ity of contraceptive methods, with the private sec-
tor generally performing better than the public
sector. Not surprisingly, in the Key Research study
a larger proportion of women in Luanda reported
obtaining their method from pharmacies, private
hospitals, or local stores (64.8%), compared
with public hospitals, health posts, and NGOs
(34.2%).29 The limited availability of contracep-
tives in the market appears to constrict women’s
choice of a contraceptive method.30 In our study,
almost one-fifth of women using contraception
reported not using their preferred method.
Among the most common reasons for non-use
was the method being difficult to obtain or not
being available where women receive family
planning (data from the 2012 Family Planning
Survey, not shown). The Retail Surveys 2014 and
2015 also show that, overall, condoms, oral con-
traceptives, and emergency contraceptives are
more widely available than other types of contra-
ceptives. Even within the public sector, where
IUDs or implants are expected to be available,
very few outlets reported having them in stock.
This is likely a contributing factor explaining why
condoms and oral contraceptive pills are the most
widely used methods, while LARC methods are
among the least known and used in Luanda.
In general, providers do not recommend LARC
because of stock-out problems, lack of training, or
beliefs that suchmethods are only forwomenwho
already have children.21 This reinforces women’s
own beliefs that condoms are the best methods
for childless women because other methods can
cause infertility.18
Knowledge, use, and availability of the male
condom has increased more sharply in sub-
Saharan Africa than in other regions of the world,
partly because it can be promoted as a dual protec-
tion method that can protect against both
unwanted pregnancy and HIV.30 In Angola, male
condoms were promoted for many years more
than any other contraceptive method and have
been offered for free or sold in a wide range of out-
lets in Luanda.31 Accordingly, the high availability
of male condoms stimulates its greater use across
all age groups.
Earlier research has shown that greater avail-
ability of different contraceptive methods is linked
with higher contraceptive prevalence rates.12
Ready access to a wide range of methods allows
each subgroup of users to find the method that
best fulfills their family planning needs.30 Thus, it
is important for a country to invest in different
contraceptive methods in order to increase
informed choice and satisfaction among users.
Allowing brand competition also helps the market
benefit women by increasing the chances of price
reduction, and consequently improving women’s
access to contraceptive methods.
Role of International Aid and of the Economic
Crisis on Contraceptive Market Landscape
According to market data analyzed in this paper,
the most available brands of condoms and oral
contraceptives are those that have been supported
by external donations. In the case of condoms, the
brands Sensual and Legal were originally intro-
duced in the Angolan market with support from
USAID and DFID (United Kingdom Department
for International Development).32 After more
than 10 years in Angola, these socially marketed,
affordably priced brands are successfully compet-
ing, as indicated by their high market share in
terms of both volume and value. In the case of
oral contraceptives, the Microgynon and Microlut
brands were introduced with support from USAID
and UNFPA to be distributed for free in the public
sector.33 However, the retail surveys found these
brands on sale in the private sector, contrary to
their initial purpose. It is not clear how these
brands leak into the private sector, but because
they offer the lowest price to consumers and com-
pete against commercial brands, there is little
space in the market share for other commercial
brands to grow: together these 2 brands represent
76.0% of the total volume of oral contraceptives.
There is limited
availability of a
range ofmethods
on themarket,
with the private
sector generally
performing better
than the public
sector.
Themost
available brands
of condoms and
pills are those that
have been
supported by
donations by
external donors.
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The leakage also reflects a weak health system
with a poor regulatory environment and limited
human resources to monitor the supply chain
operations and lack of standard operational
procedures.34
Market data also show a significant reduction
in the proportion of outlets having different types
of contraception from 2014 to 2015. The decrease
in availability translates into a price increase for
many contraceptive brands and represents a step
back in women’s choices and affordability of dif-
ferent contraceptives, especially in a country
where 56.4% of the employed population lives
on less than US$2 per day (less than 200 AKZ).35
The situation may persist in the current economic
context, in which a substantial drop in oil
prices (Angola’s main income-generating prod-
uct) has limited government’s expenditure on
health and the private sector’s capacity to import
products due to lack of international currency
(US dollars).36,37
As Angola has shifted from having a low- to
middle-income economy, the role of external
donor agencies is changing from directly purchas-
ing essential products to serving in a solely techni-
cal or advocacy role. As an example, between
2014 and 2015 UNFPA decreased the number of
Microgynon and Microlut oral contraceptive pills
donated from 349,189 to 285,730 cycles and the
number of Jadelle implants from 85,000 to 0.20 In
this context, the Angolan government will have to
increase its direct investment in contraceptive
products and play a more active part in satisfying
the need for family planning. In 2012, the govern-
ment budget represented only 10% of the total
amount spent on family planning, compared
with 30% provided by UNFPA and 60% by
USAID.21 In its plans for fiscal year 2016, the
Ministry of Health forecasted an investment cov-
ering 23.0% of the family planning budget, while
UNFPA and USAID would provide the remaining
47.0% and 29.0%, respectively.38 There is still a
long way to go toward self-sufficiency, and
Angola should continue to introduce strategies to
ensure availability and fair competition of family
planning products on themarket, while encourag-
ing demand for contraception.
Market Segmentation: Public and
Private Sectors Working Together
on Family Planning
In order to achieve universal coverage for family
planning, it is important to have cooperation and
coordination between the public and private
sectors (including civil society, NGOs and donors).
While the public sector can provide country lead-
ership by setting regulations, taxes and fees, poli-
cies, and quality standards, as well as serving the
lowest quintiles through public services, the pri-
vate sector can reach population sectors that can
afford to pay, thereby reducing the burden on the
public sector to provide free commodities broadly.
Through market segmentation, the private
sector can reach segments of the population with
some economic power interested in using family
planning, which are not usually the target of the
public sector. Preventing leakage of "free" prod-
ucts from the public sector into the private sector
(which are later sold at "unfair" prices) will assure
that (a) such products actually reach women with
limited resources, for whom they are intended,
and (b) the private sector invests more to meet
the demand of family planning for a segment that
can actually pay for it. With an interest in growing
its business, the private sector will guarantee the
availability of products that represent a margin of
profit for them, reducing the chances of stock-out.
There is the potential to expand and improve
the family planning market in the private sector
in Angola, yet this potential is not realized and is
often overlooked. Thinking in the new Angolan
context in which donors are reducing donation of
products and are focusing mostly on technical as-
sistance, it is important to consider how best to
reinforce the private sector as a complementing
component to the overall health system.
Limitations
There are some limitations in the present analysis
that should be highlighted. First, the family plan-
ning survey and the retail studies were not
conducted during the same year, preventing a
direct comparison between contraceptive use and
method availability. The 2-year difference raises
the question of whether the context was the
same when use and availability of contraceptive
methods were analyzed. To mitigate this limita-
tion, information on contraceptive use from an
OMNIBUS Study conducted by Key Research in
Luanda is incorporated in the discussion section.
The study was conducted at the same time as the
Retail Study 2015. Overall, it showed similar
patterns as the Family Planning Study 2012: a rel-
atively high reliance on male condoms and
continued low prevalence of LARC methods,
especially among young age groups
The small sample size of public-sector facilities
in the retail studies also limits the comparative
Reductions in the
proportion of
outlets having
different types of
contraception
translated into
price increases for
many brands.
Market
segmentation
would allow the
private sector to
reach those
population
segments with
someability to pay
for contraception,
thereby reducing
the burden on the
public sector to
provide free
commodities
broadly.
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analysis over time of contraceptive availability in
public health facilities. Statistical tests are less
likely to show significant differences where there
actually is a difference. This limitation cannot be
overcome; even when conducting a census of
public-sector facilities in the province (as in the
Retail Study 2014), the number of public facilities
is still limited.
Finally, the required sample size for emer-
gency contraceptive pills was not sufficiently large
enough tomeasure a change of at least 10 percent-
age points over time, so analysis about statistically
significant changes in the availability of this
method should be made with caution. The data
serve though to understand the tendency over
time in the availability of this method, which fol-
lows the same tendency reported in this article
for other methods.
CONCLUSIONS
National data show high levels of fertility in
Angola: almost 6 children per women at the end
of her reproductive life, with the adolescent fertil-
ity rate increasing over time.4,6 Many Angolan
women want to space or limit childbirth, but they
have few real opportunities to do so. This paper
shows that in Luanda province, the capital of
Angola, half of women did not want their last
pregnancy. On average, the ideal number of chil-
dren reported in this paper (4.2) is lower than the
actual number of children born to women at the
end of their reproductive life in Luanda (5.5).39
Male condoms and oral contraceptive pills are
the most available methods in Luanda and the
most used methods across all age groups. In con-
trast, fewwomen rely on implants or IUDs, at least
in part because LARC methods are less available.
Similar to other research in family planning, we
can infer that the availability or unavailability of a
contraceptive method influences its use (or non-
use). Besides availability, this article finds that
other factors such as age and awareness of a con-
traceptive method were also linked to contracep-
tive choice and use.
In order to meet the latent demand for contra-
ception, it is necessary not only to ensure the
availability and affordability of contraceptives cur-
rently on themarket, but also to expand the range
of options for women and to guarantee women’s
real access to sexual and reproductive health prod-
ucts and services. To achieve that goal, it is impor-
tant to take actions toward:
 Improving women’s knowledge about all con-
traceptive methods, including their characteris-
tics and potential side effects, aswell as reducing
current myths and misconceptions about use
of contraception, allowing women to make
informed choices
 Increasingtheavailabilityofdifferentcontracep-
tive methods in the private and public sector
with an adequate segregation of the market; for
instance, making generic or less expensive
brands available in public sector, while selling
more expensive brands in private pharmacies or
drug shops
 Improving the efficiency of supply chain distri-
bution to prevent stock-outs in the market,
while simultaneously strengthening the regula-
tory health system, to avoid leakage from the
public to the private sector, and helpingwomen
from low socioeconomic sectors to have real
access to free contraception within the public
sector
 Assuring a self-sustained market, where supply
meets—and at the same time enhances—
demand, with little dependence on donations
from international organizations
 Improving family planning services by elimi-
nating provider’s own misconceptions (only
women who already had children should
use contraception due to risks of infertility);
also through counseling and provision of all
type of methods, including LARC methods
 Advocating the inclusion of all LARC methods
on the national list of essential medicines, to
ensure availabilitywithin the public and private
sectors
Accordingly, public health policies need to
(1) ensure provision of amuchwider range of con-
traceptive methods; (2) improve the efficiency
of the supply chain distribution (with adequate
monitoring and evaluation); and (3) strengthen
demand generation activities. These actions will
have a greater impact if they are developed within
a context of strongpoliticalwill, social accountabil-
ity,andsignificantandsustainedhumanandfinan-
cial resources devoted to improve family planning
services for the benefit of all women and their
partners.
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